Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFβ
Authors:
- 1 March 1994
- journal article
- Published by SAGE Publications in Innate Immunity
- Vol. 1 (1) , 21-29
Abstract
Administration of non-lethal doses of lipopolysaccharide (LPS) to experimental animals and humans results for a short period of time in a state of hyporesponsiveness to a second LPS challenge. This phenomenon, known as endotoxin tolerance, has been reproduced in vitro using human monocytes, rendered endotoxin-tolerant following a first incubation with LPS. A further activation by LPS was manifested by a dramatically reduced production of tumor necrosis factor α (TNFα). We report this low responsiveness of LPS pretreated monocytes as an endotoxin non-specific phenomenon. Indeed, TNFα release upon further activation with either killed Gram-positive bacteria (Staphylococci, Streptococci) or zymosan was also significantly diminished. This was not the case when phorbol myristate acetate (PMA) was used as a second triggering agent, suggesting that the monocyte hyporesponsiveness due to LPS does not affect all activation pathways, particularly that of protein kinase C. On the other hand, both PMA and zymosan pretreatment could reduce a further activation of monocytes by LPS. We investigated whether the first signal(s) delivered by LPS, could be mimicked by some of the LPS-induced cytokines. Preincubation of monocytes with either interleukin-1 (IL-1), IL-10 or transforming growth factor β (TGFβ) lower the TNFα production upon further activation with LPS. None of the cytokines alone was as efficient as the LPS molecule, but high levels of tolerization were obtained with combination of IL-1, IL-10 and TGFβ. Neither IL-6, IL-8 nor TNFα led to hyporeactive cells. Our data indicate that endotoxin tolerance is not an LPS-specific phenomenon and that more than one cytokine can contribute to render human monocytes hyporeactive to further activation by LPS.Keywords
This publication has 46 references indexed in Scilit:
- Desensitization of Macrophages to Endotoxin Effects Is Not Correlated with a Down-Regulation of Lipopolysaccharide-Binding SitesCellular Immunology, 1993
- Pre‐exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activityEuropean Journal of Immunology, 1993
- Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages.Journal of Experimental Medicine, 1993
- Endotoxin tolerance: In vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional levelCellular Immunology, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.Journal of Experimental Medicine, 1991
- Glucocorticoid‐dependent and ‐independent mechanisms involved in lipopolysaccharide toleranceEuropean Journal of Immunology, 1991
- Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and menCritical Care Medicine, 1991
- Endotoxin-Refractory Liver Macrophages Secrete Tumor Necrosis Factor-α upon Viral InfectionBiological Chemistry Hoppe-Seyler, 1991
- Human T cells and interleukin 4 inhibit the release of interleukin 1 induced by lipopolysaccharide in serumfree cultures of autologous monocytesEuropean Journal of Immunology, 1989
- MECHANISMS OF ENDOTOXIN TOLERANCEJournal of Experimental Medicine, 1965